Home » News » “FDA” warns: “Belvik” drug used to reduce weight increases the risk of cancer

“FDA” warns: “Belvik” drug used to reduce weight increases the risk of cancer

The US Food and Drug Administration has warned (FDA), From Bilvik ” BELVIQ “Used to reduce weight, because it causes cancer, which is discharged as” Belvik XR, “which is likely to increase the risk of cancer,” the (FDA), In a recent statement that the results of a clinical trial tested the safety of the drug, also known as “lorcaserin”, and revealed the possibility of an increased risk of cancer.


FDA warns of weight loss drug

“At this time, the cause of cancer is uncertain, and we cannot conclude that (Lorcaserin) is contributing to the risk of developing cancer, however, we wanted to make people aware of this potential risk,” the panel said.

Medicine to lose weight may cause cancer

Medicine to lose weight may cause cancer

“Newsweek” noted that “FDA“She is currently reviewing the results of the clinical trial, and plans to publish her final conclusions and recommendations as soon as this process is complete, explaining that patients currently taking Lorcaserin should talk to their health care professional about the possible increased risk of developing cancer using it, and advised the healthcare professional, To consider whether the benefits of taking the drug outweigh the potential risks when deciding to prescribe or keep patients on Lorcaserin, doctors were also asked to report side effects of the Safety Information Program, and report adverse events.

It is always recommended to exercise and eat healthy food when losing weight
It is always recommended to exercise and eat healthy food when losing weight

She asked (FDA) From the manufacturer to conduct a clinical trial to verify that the drug does not increase the risk of heart disease, about 12 thousand participants participated over the 5-year period, and at the end of the study, a greater number of patients taking the drug were diagnosed with cancer more than those who took the drug Phantom.

Belvik weight loss drug may cause cancer
Belvik weight loss drug may cause cancer

“Our assessment of this possible sign is ongoing, and at this time it is not certain whether lorcaserin increases the risk of cancer,” the panel said.

The Food and Drug Authority warns against Belvik to reduce weight
The Food and Drug Authority warns against Belvik to reduce weight

The magazine recommended patients to speak directly with a healthcare professional in order to make the best decision about their medical treatment. The magazine pointed out that this drug was approved in 2012, as it helps in losing weight for overweight and obese patients, who suffer from medical problems related to weight, patients are advised to adhere to a diet that is controlled from calories and increase their exercise levels while using it.

In August 2018, the drug was praised in the fight against obesity after a study published in the New England Journal of Medicine, which yielded promising results. The magazine said: “Although this drug may seem an easy option for weight loss, it was assumed that the participants in this study would take the drug along with a diet and exercise plan.”

– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.